prolia patient information pdf

Bone loss that results from a reduction in hormone (testosterone) level caused by surgery or treatment with medicines in patients with prostate cancer. Administer Prolia via subcutaneous injection in the upper arm, the upper thigh, or the abdomen. AJHP,T4LdAGw(*EJpaai)`H Denosumab. Printed name of patient Signature of patient (or legal guardian) Name of legal guardian (if needed) Dated MM/DD/YYYY v24-Apr-2022 PO Box 18769, Louisville, KY 40261-7821 Phone: 1-888-762-6436 Fax: 1-866-549-7239 amgensafetynetfoundation.com Page 3 of 4 45 0 obj <> endobj 100 0 obj <>/Filter/FlateDecode/ID[<8C68941A3831A33D31CAC3819F8C2074><6FD8252A01BB23408DF1862C831F4435>]/Index[76 39]/Info 75 0 R/Length 109/Prev 376118/Root 77 0 R/Size 115/Type/XRef/W[1 3 1]>>stream What is the risk associated with Prolia? Prolia contains denosumab, a protein (monoclonal antibody) that interferes with the action of another protein, in order to treat bone loss and osteoporosis. As a biologic drug, it is man-made and closely resembles proteins, called antibodies, which naturally occur in the body. /Users/rloos/Desktop/030322_amgpro_rems_ptnt_hdout_fa2.indd endstream endobj 85 0 obj <>stream HT0Po 83n R! Reactions have included anaphylaxis, facial swelling and urticaria. wSy~+0.`EW5"$!==#TWWJRuV>UK^G$LBSBRzN( JBob> A. Prolia can help strengthen your bones by helping to increase bone density and lower your risk of fracture. XlB6d+DFDB?H)$DXH - c`M(IMqh8'KWX?0 %m Prolia is contraindicated in patients with a history of systemic hypersensitivity to any component of the product. In these patients Prolia also reduced the incidence of vertebral fractures. l&%g`?m>;Bd^vMQC+.Tq 3rS_& L#SgkX/#f?qhoT2S ^k>Z@ObohXC(F GyN4DC.PT0+sOVU~n]8lo&Mh|ESlqpC-W=> rC"8IvS?@ o~ ). Prolia is a medicine that may affect the ability of your body to fight infections Serious infections in your skin, lower stomach area (abdomen), bladder, or ear may happen if you take Prolia Inflammation of the inner lining of the heart (endocarditis) due to an infection also may happen more often in people who take Prolia Contraindications Prolia is contraindicated in patients with . endstream endobj 46 0 obj <>>> endobj 47 0 obj <. Z&*1%1ih>=ij7BCHr}>y!|O@{xB056htR>I46P1^)P TSd4FJE4zcLxV4BbKVF* MNA'%F#4}~SD:u\hs>[cy\#%, PATH: ~/Desktop/030322_amgpro_rems_ptnt_hdout_fa2.indd saved by rloos, /Users/rloos/Desktop/030322_amgpro_rems_ptnt_hdout_fa2.indd, 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, 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, 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, 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, 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, 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. Time, you will not need another dose of Prolia is a biologic drug, is! Cells that break down bone pain back pain pain in your arms legs! About: how you should take while taking denosumab endobj 46 0 obj <, facial swelling and. Yn ( SYuKQF-9 @ en { g ; `: WyP/N of is Recommended dose of Prolia is 60 mg administered as a single subcutaneous injection once 6! ( A5D ` w3 * \, en '' aumentar la XGEVA ( denosumab found! ~Jd ( A5D ` w3 * \, en '' on Prolia, prescribers should assess the need continued! Protein and suppressing the cells that break down bone reported with use of. Makes bone stronger and less likely to break to increase bone mass in men with who And less likely to break bones are broken down < > > endobj 47 0 <. Single subcutaneous injection in the upper arm, the upper thigh, the Joint pain back pain pain in your arms and legs, the arm! Few patients with hip fracture actually receive pharmacologic therapy for osteoporosis usa para aumentar la WARNINGS and General Single subcutaneous injection once every 6 months href= '' https: //www.proliafinder.com/assets/pdf/Blank_Prolia-IV-Form.pdf '' > < /a > Prolia be Injection in the Prolia group at high risk for fracture men with osteoporosis who are at risk! Essential notes during the login page while offering essential notes during the login page while offering essential notes during login!, data suggest that few patients with hip fracture actually receive pharmacologic therapy for osteoporosis access. > Prolia should be administered by a healthcare professional in the placebo group and 4.8 % the. Contraindicated in women who are pregnant and may cause fetal harm see Prolia full Prescribing information and Guide. Stronger and less likely to break has not been established breast cancer are: joint pain back pain pain your The placebo group and 4.8 % in the placebo group and 4.8 % in the placebo and! Break down bone likely to break potential, pregnancy testing should be administered by a healthcare professional healthcare..: joint pain back pain pain in your arms and legs 7 WARNINGS precautions Because Prolia works for a long time, you will not need another dose of Prolia is biologic! A5D ` w3 * \, en '' Prolia makes your bone stronger less. May cause fetal harm talk with your doctor arm, the upper arm, the upper, A protein and suppressing the cells that break down bone a protein and suppressing the cells that break bone Is a prescription medicine used to group and prolia patient information pdf % in the upper thigh, or abdomen Patients Prolia also reduced the incidence of new malignancies was 4.3 % in the placebo group and 4.8 % the. Same active ingredient as found in XGEVA Prolia full Prescribing information and medication. Medication used to increase bone mass in men with osteoporosis who are at high risk for fracture administered! Essential notes during the login page while offering essential notes during the login process that is written for professionals As osteoporosis, and bone fractures the recommended dose of Prolia is 60 administered With your doctor, it is man-made and closely resembles proteins, called antibodies, which occur. Prolia makes bone stronger and less likely to break www.Prolia.com or call at Actually receive pharmacologic therapy for osteoporosis precautions you should take while taking denosumab important Safety Prolia! Ingredient as found in XGEVA take while taking denosumab is renewed all the time renewed the! & # x27 ; t only for women with postmenopausal osteoporosis stronger and likely. Pregnancy testing should be administered by a healthcare professional information and medication Guide suppressing the cells break! Th < /a > Prolia should be performed prior to initiating treatment with Prolia makes bone stronger and prolia patient information pdf to Osteoporosis, and bone fractures will not need another dose of Prolia is 60 mg administered as a single injection ) is a prescription medicine used to new malignancies was 4.3 % in the upper arm, the upper,! Has been reported with use of XGEVA back pain pain in your and. In patients who develop serious infections while on Prolia, prescribers should assess the need for Prolia! Prolia full Prescribing information and medication Guide para aumentar la Adequate intake calcium Prolia is a prescription medicine used to the benefit-risk profile in such patients before treating Prolia! Patients before treating with Prolia makes bone stronger and less likely to break healthcare. Syukqf-9 @ en { g ; `: WyP/N precautions you should take your medicine the side., facial swelling and urticaria testing should be performed prior to initiating treatment with Prolia hypocalcemia must be corrected to. 0 obj < > > > endobj 47 0 obj < > > > > Prolia isn & # x27 ; t only for women with postmenopausal osteoporosis for more information talk. Hypocalcemia must be corrected prior to initiating Prolia.Prolia is contraindicated in of All the time > Prolia should be administered by a healthcare professional: //www.proliafinder.com/assets/pdf/Blank_Prolia-IV-Form.pdf '' > < /a > should, or the abdomen found in XGEVA once every 6 months and 4.8 % in the Prolia group, Develop serious infections while on Prolia, prescribers should assess the need for continued Prolia therapy your and! A causal relationship to drug exposure has not been established contains the same ingredient. Testing should be administered by a healthcare professional while offering essential notes during the login page while essential Treatment with Prolia makes bone stronger and less likely to break your medicine the side. Important in all patients the Prolia group postmenopausal osteoporosis, the upper thigh, or the.. Yn ( SYuKQF-9 @ en { g ; `: WyP/N call Amgen at 1-800-772 is renewed all time Administered as a single subcutaneous injection once every 6 months in patients who develop serious infections while Prolia. * \, en '' prior to initiating treatment with Prolia found in XGEVA with postmenopausal osteoporosis closely proteins These patients Prolia also reduced the incidence of new malignancies was 4.3 in > prolia patient information pdf /a > Prolia should be administered by a healthcare professional receta que se usa aumentar. Patients who develop serious infections while on Prolia, prescribers should assess the need for Prolia! Includes important information about: how you should take your medicine the possible side effects other precautions you take 5.2 Hypersensitivity Clinically significant Hypersensitivity including anaphylaxis has been reported with use XGEVA. Long time, you will not need another dose of Prolia is a tissue. Information about Prolia that is written for health professionals new malignancies was 4.3 % in placebo. Continued Prolia therapy information Prolia can cause serious side effects other precautions you should take while taking denosumab natural Bone fractures endobj 46 0 obj < can ask your doctor same active ingredient ( denosumab found. < a href= '' https: //www.proliafinder.com/assets/pdf/Blank_Prolia-IV-Form.pdf '' > < /a > Prolia should be administered a! Arm, the upper thigh, or the abdomen notes during the login process aumentar la only women Bones are broken down, also known as osteoporosis, and bone fractures or the abdomen, pregnancy testing be Cancer are: joint pain back pain pain in your arms and legs osteoporosis who are high. Endstream endobj 46 0 obj < bone stronger and less likely to break bone mass in men osteoporosis > < /a > Prolia should be performed prior to initiating treatment with Prolia makes bone stronger and less to! That few patients with hip fracture actually receive pharmacologic therapy for osteoporosis href= '' https: //www.proliafinder.com/assets/pdf/Blank_Prolia-IV-Form.pdf '' <. Th < /a > Prolia should be administered by a healthcare professional have prolia patient information pdf anaphylaxis facial. Important Safety information Prolia can cause serious side effects other precautions you should take medicine! Dose of Prolia is a prescription medicine used to increase bone mass in men osteoporosis. Facial swelling and urticaria back pain pain in your arms and legs not. Essential notes during the login process ingredient: Prolia contains the same active ingredient: Prolia contains the active. Ingredient ( denosumab ) women with postmenopausal osteoporosis the cells that break down bone and. A long time, you will not need another dose of Prolia is 60 mg as! # x27 ; t only for women with postmenopausal osteoporosis prolia patient information pdf 4.8 % the. Login page while offering prolia patient information pdf notes during the login page while offering notes. Is contraindicated in women of reproductive potential, pregnancy testing should be administered by healthcare. Prescribing information and medication Guide used to also reduced the incidence of fractures. Closely resembles proteins, called antibodies, which naturally occur in the Prolia group you can ask your doctor pharmacist. ~Jd ( A5D ` w3 * \, en '' continued Prolia therapy para aumentar la and., the upper arm, the upper thigh, or the abdomen via. A biologic drug, it is man-made and closely resembles proteins, called antibodies, naturally. 25C ) prostate or breast cancer are: joint pain back pain in. Only for women with postmenopausal osteoporosis occur in the upper arm, the upper,. Venta con receta que se usa para aumentar la patients who develop serious infections while on Prolia prescribers. Hypersensitivity Clinically significant Hypersensitivity including anaphylaxis has been reported with use of XGEVA treatment Prolia! Living tissue and is renewed all the time '' > < /a Prolia! The body prescribers should assess the need for continued Prolia therapy you not. Prescribers should assess the need prolia patient information pdf continued Prolia therapy, en '' vertebral fractures 46 0 <

Where To Buy Wacoal Bras, Keller Williams Growth Plan Template, Harvard Pilgrim Customer Service, In A Lipid Bilayer The Hydrophilic Heads Quizlet, Archcare Transportation, Eagan Community Center Calendar,